The Peptide Drug Hunting Consortium is excited to announce another new Leadership Team member, Ved Srivastava! We look forward to understanding, strengthening, and expanding the science/technology-business of peptide therapeutics together. Look for new EAB members announcement next week!
About us
Enabling the strategic scientific and business needs of peptide drug hunters throughout the world with respect to biotechs, academic spin-outs, CROs/CMDOs/service orgs, pharma partners, and investors.
- Industry
- Education
- Company size
- 2-10 employees
- Type
- Privately Held
Employees at Peptide Drug Hunting Consortium
-
Tomi Sawyer
Chief Drug Hunter & President at Maestro Therapeutics
-
Gordon Carlson
Business Development at Rilas Technologies
-
Jonathon Sawyer
Founder Scientist and Head at Peptide Scientia
-
Ryuji Hayashi
Group Head, Discovery Chemistry Department, Research Division at Chugai Pharmaceutical Co., Ltd.
Updates
-
The Peptide Drug Hunting Consortium is excited to announce our new Leadership Team member, Katerina Leftheris, Ph.D.. We look forward to understanding, strengthening, and expanding the science/technology-business of peptide therapeutics together.
-
Peptide Drug Hunting Consortium reposted this
Tomi Sawyer, founder of Maestro Therapeutics is back again this year and his talk title is "Peptide Drug Hunting: Innovative Science & Technology Empowering Breakthrough Medicines" Join us on Wednesday, October 9th to learn about New Modalities research. Click below to register for free. #newmodalities #proteins #peptides #antibioticresistance #drugdiscovery https://lnkd.in/edCH-5bM
-
The Peptide Drug Hunting Consortium extends our heartfelt thanks to our followers and members for helping us reach an exciting milestone of 1,500 followers. As we expand our Entrepreneurial Advisory Board and launch our new Entrepreneurial Business Network, we are also in the process of creating a dedicated website and transitioning into a non-profit organization. While we build our consortium and develop our initiatives, we invite all peptide drug hunters to connect with us on LinkedIn and contribute to our page. Send us a message for an opportunity to repost and/or highlight educational and job opportunities, webinars, symposiums, collaborations, and networking events that contribute to driving peptide research and therapeutics forward. We are dedicated to help make a difference in the future R&D and clinical success of peptide drugs worldwide! All the Best, Tomi Sawyer and the PDHC Leadership Team
-
-
Congratulations to our Founding Sponsor Maestro Therapeutics on their 5th Anniversary! 🎉 We look forward to hearing more about the emerging Peptide Drug Discovery Force Alliance 😀
Fifth Anniversary of Maestro Therapeutics –– Entrepreneurial Drug Discovery! I’m pleased to share this special announcement of the 5th Anniversary of Maestro Therapeutics as an entrepreneurial R&D/BD&L consulting/advisory business to advance peptide drug discovery! Maestro Therapeutics strives to bring multidisciplinary expertise, science and technology know-how as well as the spirit of teamwork in supporting biotechs, pharma and venture capital worldwide. We celebrate every success, from a single experiment to a milestone proof-of-concept achievement or a winning deal between our biotech partners and their investors. Scholarship and mentorship are critical to our modus operandi to support R&D/BD&L goals. This post includes a Maestro Therapeutics’ collage to capture the essence of our past and emerging business enterprise. This will include a future e-Chronicle (Peptide Drug Discovery Force) and a website. We’re creating a Peptide Drug Discovery Force Alliance with seasoned multidisciplinary drug hunters, distinguished KOLs, and liaison with expert contract R&D organizations that will provide greater impact to our partnerships. Our R&D/BD&L strategic vision is focused on the entrepreneurial science/business interface, and we are pleased to be a Founding Sponsor of the Peptide Drug Hunting Consortium! On behalf of the Maestro Therapeutics leadership team and our emerging Peptide Drug Discovery Force Alliance, I wish all peptide drug hunters good luck and future success! Tomi Sawyer, Founding Chief Drug Hunter, Maestro Therapeutics #peptides #peptidetherapeutics
-
-
PDHC's EAB members enjoying lunch at the BPS! Anastasia Velentza Wendy Hartsock Sepideh Afshar Gordon Carlson Matteo Villain, Pharm.D. Fernando Albericio Ewa Lis Elizabeth Denton Dominik Sarma #peptides #BPS2024
-
-
The Peptide Drug Hunting Consortium leadership team is excited to announce our Inaugural Entrepreneurial Advisory Board is growing and to welcome our new members. We look forward to leveraging their expertise, wisdom, ideas, and contributions for our initiatives that will help make a difference in the future R&D and clinical success of peptide drugs worldwide. Stay tuned for additional EAB member announcements! #peptides #peptidetherapeutics
-
The PDHC has initiated the creation of an Entrepreneurial Business Network (EBN) to engage all contract R&D research organizations and service providers who are supporting peptide drug discovery. We look forward to our Entrepreneurial Advisory Board and our new Entrepreneurial Business Network working together to bridge science and business and help make a difference in the future R&D and clinical success of peptide drugs worldwide. Stay tuned for additional EAB and EBN member announcements!
-
The Peptide Drug Hunting Consortium leadership team is excited to announce our Inaugural Entrepreneurial Advisory Board is growing and to welcome our new members. We look forward to leveraging their expertise, wisdom, ideas, and contributions for our initiatives that will help make a difference in the future R&D and clinical success of peptide drugs worldwide. Stay tuned for additional EAB member announcements! #peptides #peptidetherapeutics